Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Epidemiol Prev ; 41(1): 46-53, 2017.
Artigo em Italiano | MEDLINE | ID: mdl-28322528

RESUMO

"OBJECTIVES: to investigate the increase of PM10 during Saharan dust outbreaks with adverse health effects in Sicily (Southern Italy), the largest Mediterranean Island. DESIGN: pooled analyses of time series with Poisson regression models to estimate the association between PM10 from different sources (desert and non-desert) and different outcomes. SETTING AND PARTICIPANTS: the four largest cities of Sicily (Palermo, Catania, Syracuse, and Messina) and three macroareas (North- East, South, and West) Sicily was divided into. MAIN OUTCOME MEASURES: daily count of cause-specific (ICD-9 codes) mortality and hospital admissions: natural (0-799), cardiovascular (390-459), and respiratory causes (460-519). RESULTS: 962 days affected by Saharan dust (30% of all days: 2,257) were identified. Significant associations between desert PM10 and natural mortality both in the cities and in the macro-areas were found, with increases of risk and 95% confidence intervals equal to 1.1% (95%CI 0.1-2.1) and 1.1% (95%CI 0.8-1.5) per 10 µg/m3 increase in lag 0-1 PM10, respectively. Weaker estimates were found for cardiorespiratory mortality. Desert PM10 displayed an association with respiratory hospitalizations, especially in the three macroareas (0.5%; 95%CI 0.1-1.0). In contrast, cardiovascular hospitalizations were associated only with non-desert PM10 in the four cities (1.3%; 95%CI 0.4- 2.1%). Higher desert PM10-related mortality was found during the warmer months (period: April-September): 2.7% (95%CI 0.8-4.5) in the four cities and 2.5% (95%CI 1.8%-3.2%) in the three macroareas. CONCLUSIONS PM10 originating from desert was positively associated with mortality and hospitalizations in Sicily. Policies should aim to reduce anthropogenic emissions even in areas with large contribution from desert sources."


Assuntos
Poluição do Ar/efeitos adversos , Doenças Cardiovasculares/epidemiologia , Poeira , Hospitalização/estatística & dados numéricos , Material Particulado/análise , Doenças Respiratórias/epidemiologia , Estações do Ano , África do Norte , Poluentes Atmosféricos/análise , Doenças Cardiovasculares/mortalidade , Cidades , Clima Desértico , Feminino , Humanos , Masculino , Doenças Respiratórias/mortalidade , Sicília/epidemiologia , Fatores de Tempo
2.
Hemoglobin ; 39(4): 225-9, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26016899

RESUMO

Phenotypic improvement of hemoglobinopathies such as sickle cell disease and ß-thalassemia (ß-thal) has been shown in patients with high levels of Hb F. Among the drugs proposed to increase Hb F production, hydroxyurea (HU) is currently the only one proven to improve the clinical course of these diseases. However, Hb F increase and patient's response are highly variable, indicating that new pharmacological agents could be useful for patients not responding to HU or showing a reduction of response during long-term therapy. In this study we evaluated the efficacy of rapamycin, a lypophilic macrolide used for the prevention of acute rejection in renal transplant recipients, as an inducer of Hb F production. The analyses were performed in cultured erythroid progenitors from 25 sickle cell disease and 25 ß-thal intermedia (ß-TI) patients. The use of a quantitative Real-Time-polymerase chain reaction ReTi-PCR technique and high performance liquid chromatography (HPLC) allowed us to determine the increase in γ-globin mRNA expression and Hb F production in human erythroid cells treated with rapamycin. The results of our study demonstrated an increase in vitro of γ-globin mRNA expression in 15 sickle cell disease and 14 ß-TI patients and a corresponding Hb F increase. The induction by rapamycin, even if lower or similar in most of samples analyzed, in some cases was higher than HU. These data suggest that rapamycin could be a good candidate to be used in vivo for the treatment of hemoglobinopathies.


Assuntos
Anemia Falciforme/genética , Células Precursoras Eritroides/efeitos dos fármacos , Células Precursoras Eritroides/metabolismo , Hemoglobina Fetal/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Sirolimo/farmacologia , Talassemia beta/genética , Adolescente , Adulto , Idoso , Anemia Falciforme/tratamento farmacológico , Anemia Falciforme/metabolismo , Células Cultivadas , Feminino , Hemoglobina Fetal/metabolismo , Genótipo , Humanos , Hidroxiureia/farmacologia , Hidroxiureia/uso terapêutico , Masculino , Pessoa de Meia-Idade , Mutação , Adulto Jovem , alfa-Globinas/genética , alfa-Globinas/metabolismo , Globinas beta/genética , Globinas beta/metabolismo , Talassemia beta/tratamento farmacológico , Talassemia beta/metabolismo , gama-Globinas/genética , gama-Globinas/metabolismo
3.
Eur J Haematol ; 92(1): 66-72, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24112139

RESUMO

BACKGROUND AND OBJECTIVE: Increased expression of fetal hemoglobin (HbF) may ameliorate the clinical course of hemoglobinopathies like sickle cell disease (SCD) and ß-thalassemia. Hydroxyurea (HU) can stimulate HbF production in these diseases but the response is highly variable indicating the utility of developing an in vitro test to predict the patient's response to HU. We assessed whether the HbF response of patients with SCD and thalassemia intermedia (TI) to HU correlates with HBG (both γ-globin genes) expression in their cultured erythroid progenitors following exposure to HU. PATIENTS AND METHODS: We exposed primary erythroid cultures from peripheral blood mononuclear cells from 30 patients with SCD and 15 with TI to HU and measured HBG mRNA by real-time quantitative PCR. The same patients were then treated with HU and their HbF response after treatment with a stable dose of HU was compared with the mRNA results in cultured cells. RESULTS AND CONCLUSION: The fold increase in HBG mRNA in erythroid progenitors was similar to the fold increase in HbF in vivo. Quantification of HBG mRNA in erythroid progenitor cell cultures from patients with SCD and TI is predictive of their clinical response to HU.


Assuntos
Anemia Falciforme/genética , Células Precursoras Eritroides/metabolismo , Talassemia beta/genética , gama-Globinas/genética , Adulto , Idoso , Anemia Falciforme/sangue , Anemia Falciforme/tratamento farmacológico , Feminino , Hemoglobina Fetal/genética , Expressão Gênica , Humanos , Hidroxiureia/administração & dosagem , Hidroxiureia/uso terapêutico , Masculino , Pessoa de Meia-Idade , Cultura Primária de Células , RNA Mensageiro/genética , Resultado do Tratamento , Adulto Jovem , Talassemia beta/sangue , Talassemia beta/tratamento farmacológico
4.
Br J Haematol ; 151(5): 509-15, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20955403

RESUMO

Hydroxycarbamide (HC) is a pharmacological agent capable of stimulating fetal haemoglobin (HbF) production during adult life. High levels of HbF may ameliorate the clinical course of ß-thalassaemia and sickle cell disease. The efficacy of HC for the treatment of thalassaemia major and thalassaemia intermedia is variable. Although an increase of HbF has been observed in most patients, only some patients experience significant improvement in total haemoglobin levels. This study aimed to determine the effectiveness and safety of short- (1 year) and long-term (mean follow-up 68 months) HC treatment in 24 thalassaemia intermedia patients. Additionally, we evaluated if primary erythroid progenitor cells cultured from treated patients responded to HC treatment in a manner similar to that observed in vivo. Our results confirm a good response to HC after a short-term follow-up in 70% of thalassaemia intermedia patients and a reduction of clinical response in patients with a long follow-up. Erythroid cultures obtained from patients during treatment reproduced the observed in vivo response. Interestingly, haematopoietic stem cells from long-term treated patients showed reduced ability to develop into primary erythroid cultures some months before the reduction of the 'in vivo' response. The mechanism of this loss of response to HC remains to be determined.


Assuntos
Células Precursoras Eritroides/efeitos dos fármacos , Hidroxiureia/uso terapêutico , Talassemia beta/tratamento farmacológico , Adolescente , Adulto , Células Cultivadas , Esquema de Medicação , Tolerância a Medicamentos , Eritropoese/efeitos dos fármacos , Feminino , Hemoglobina Fetal/biossíntese , Seguimentos , Genótipo , Hematopoese Extramedular/efeitos dos fármacos , Hemoglobinas/metabolismo , Humanos , Hidroxiureia/administração & dosagem , Hidroxiureia/efeitos adversos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Adulto Jovem , Talassemia beta/sangue , Talassemia beta/genética
5.
Mol Ther ; 17(8): 1434-41, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19352322

RESUMO

Silencing and position-effect (PE) variegation (PEV), which is due to integration of viral vectors in heterochromatin regions, are considered significant obstacles to obtaining a consistent level of transgene expression in gene therapy. The inclusion of chromatin insulators into vectors has been proposed to counteract this position-dependent variegation of transgene expression. Here, we show that the sea urchin chromatin insulator, sns5, protects a recombinant gamma-retroviral vector from the negative influence of chromatin in erythroid milieu. This element increases the probability of vector expression at different chromosomal integration sites, which reduces both silencing and PEV. By chromatin immunoprecipitation (ChIP) analysis, we demonstrated the specific binding of GATA1 and OCT1 transcription factors and the enrichment of hyperacetylated nucleosomes to sns5 sequences. The results suggest that this new insulator is able to maintain a euchromatin state inside the provirus locus with mechanisms that are common to other characterized insulators. On the basis of its ability to function as barrier element in erythroid milieu and to bind the erythroid specific factor GATA1, the inclusion of sns5 insulator in viral vectors may be of practical benefit in gene transfer applications and, in particular, for gene therapy of erythroid disorders.


Assuntos
Cromatina/metabolismo , Vetores Genéticos/genética , Elementos Isolantes/fisiologia , Retroviridae/genética , Ouriços-do-Mar/genética , Animais , Linhagem Celular Tumoral , Imunoprecipitação da Cromatina , Efeitos da Posição Cromossômica , Fator de Transcrição GATA1/metabolismo , Elementos Isolantes/genética , Camundongos , Células NIH 3T3 , Fator 1 de Transcrição de Octâmero/metabolismo , Ligação Proteica
6.
Br J Haematol ; 141(5): 720-7, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18422777

RESUMO

Increased expression of fetal haemoglobin (HbF) may ameliorate the clinical course of beta-thalassemia and sickle cell disease. Some pharmacological agents, such as hydroxycarbamide (HC), can increase fetal haemoglobin synthesis during adult life. Cellular selection and/or molecular mechanisms have been proposed to account for this increase. To explore the mechanism of action of HC we focused on homozygous Hb-Lepore patients that presented with high fetal haemoglobin levels and were good responders to HC treatment "in vivo". We performed primary erythroid cultures from peripheral blood of four homozygous Lepore patients. The increase in HBG (gamma-globin) transcription levels and HbF content in these cultures, after HC treatment, were detected by quantitative real time polymerase chain reaction analysis and flow cytometric analysis. Primary transcript "in-situ" hybridization analysis showed a 2-fold increase in the number of cells expressing both HBG alleles in HC-treated erythroid cultures. These studies, demonstrating the larger number of biallelic HBG expressing cells, suggest that HC is able to stimulate the activation of HBG transcription. These observations provide evidences that the molecular mechanism of action is involved in the increase of fetal haemoglobin production by HC.


Assuntos
Células Eritroides/efeitos dos fármacos , Globinas/biossíntese , Hemoglobinas Anormais/genética , Hidroxiureia/farmacologia , Talassemia beta/sangue , Células Cultivadas , Hemoglobina Fetal/biossíntese , Globinas/genética , Humanos , Hibridização in Situ Fluorescente , RNA Mensageiro/genética , Transcrição Gênica/efeitos dos fármacos , Talassemia beta/genética
7.
Environ Int ; 120: 472-479, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30145311

RESUMO

BACKGROUND: Increased PM10 concentrations are commonly observed during Saharan dust advections. Limited epidemiological evidence suggests that PM10 from anthropogenic and desert sources increase mortality. We aimed to evaluate the association between source-specific PM10 (non-desert and desert) and cause-specific mortality in Sicily during 2006-2012 period. METHODS: Daily PM10 concentrations at 1-km2 were estimated in Sicily using satellite-based data, fixed monitors and land use variables. We identified Saharan dust episodes using meteorological models, back-trajectories, aerosol maps, and satellite images. For each dust day, we estimated desert and non-desert PM10 concentrations. We applied a time-series approach on 390 municipalities of Sicily to estimate the association between PM10 (non-desert and desert) and daily cause-specific mortality. RESULTS: 33% of all days were affected by Saharan dust advections. PM10 concentrations were 8 µg/m3 higher during dust days compared to other days. We found positive associations of both non-desert and desert PM10 with cause-specific mortality. We estimated percent increases of risk (IR%) of non-accidental mortality equal to 2.3% (95% Confidence Interval [CI]: 1.4, 3.1) and 3.8% (3.2, 4.4), per 10 µg/m3 increases in non-desert and desert PM10 at lag 0-5, respectively. We also observed significant associations with cardiovascular (2.4% [1.3, 3.4] and 4.5% [3.8, 5.3]) and respiratory mortality (8.1% [6.8, 9.5], and 6.3% [5.4, 7.2]). We estimated higher effects during April-September, with IR% = 4.4% (3.2, 5.7) and 6.3% (5.4, 7.2) for non-desert and desert PM10, respectively. CONCLUSIONS: Our results confirm previous evidence of harmful effects of desert PM10 on non-accidental and cardio-respiratory mortality, especially during the warm season.


Assuntos
Poluentes Atmosféricos/análise , Mortalidade , Material Particulado/análise , África do Norte , Poluição do Ar/análise , Cidades , Humanos , Imagens de Satélites , Estações do Ano , Sicília/epidemiologia
8.
Artigo em Inglês | MEDLINE | ID: mdl-28569083

RESUMO

The aetiology of amyotrophic lateral sclerosis (ALS), a rare and extremely severe neurodegenerative disease, has been associated with magnetic fields exposure. However, evidence for such a relation in the general population is weak, although the previous null results might also be due to exposure misclassification, or a relationship might exist only for selected subgroups. To test such a hypothesis we carried out a population-based case-control study in two Northern and Southern Italy regions, including 703 ALS cases newly diagnosed from 1998 to 2011 and 2737 controls randomly selected from the residents in the study provinces. Overall, we found that a residence near high-voltage power lines, within the corridors yielding a magnetic fields of ≥0.1 µT, was not associated with an excess disease risk, nor did we identify a dose-response relationship after splitting the exposed corridor according to the 0.1, 0.2 and 0.4 µT cut-points of exposure. These results were confirmed taking into account age at onset, period of diagnosis, sex, geographical area, and length of exposure. Overall, despite the residual possibility of unmeasured confounding or small susceptible subgroups not identified in our study, these results appear to confirm that the exposure to magnetic fields from power lines occurring in the general population is not associated with increased ALS risk.


Assuntos
Esclerose Lateral Amiotrófica/epidemiologia , Eletricidade , Campos Magnéticos , Exposição à Radiação/análise , Exposição à Radiação/estatística & dados numéricos , Lesões por Radiação/epidemiologia , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Esclerose Lateral Amiotrófica/diagnóstico , Feminino , Humanos , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Prevalência , Doses de Radiação , Fatores de Risco , Distribuição por Sexo
9.
Exp Hematol ; 33(11): 1363-70, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16263421

RESUMO

OBJECTIVE: Autonomous gene silencing and gene competition by globin promoters for locus control region (LCR) function have been proposed as mechanisms in developmental regulation of beta-like genes. deltabeta degrees thalassemias are syndromes presenting an increased production of fetal hemoglobin in adult life; the majority of them are due to various deletions in beta-globin gene cluster. We studied samples from double heterozygotes for beta-thalassemia and for Lepore or Sicilian deltabeta degrees deletions, both lacking beta-promoter sequence. Our goal was to address the question of whether the allele carrying the deltabeta degrees deletion is responsible for high level of fetal hemoglobin (HbF) production. PATIENTS AND METHODS: We analyzed the globin gene transcription in human erythroid cell cultures from peripheral blood stem cells, using primary transcript in situ hybridization. We performed primary erythroid cultures from patients with the following genotypes: Lepore/beta degrees 39, Sicilian deltabeta degrees /beta degrees 39, and, as controls, two thalassemia patients with nondeletional mutations (IVS1,6/IVS1,6; IVS1,6/beta degrees 39), and one normal individual. RESULTS: The cells where it is possible to unambiguously assign gamma genes transcription in cis with the deletion (gamma:beta) are strongly represented with respect to the nine other combinations of gamma and beta hybridization signals. These cells are at least nine times more represented than those expressing the gamma allele in trans to the deletion. CONCLUSION: The allele-specific transcription of fetal genes in cis with the deletion is favored in both deletional genotypes. The absence of the adult promoter may influence LCR recruitment by fetal promoter, supporting the hypothesis that competition mechanism and gene silencing can coexist in regulating human globin gene transcription.


Assuntos
Alelos , Células Eritroides/metabolismo , Hemoglobina Fetal/genética , Globinas/genética , Talassemia/sangue , Transcrição Gênica , Células Cultivadas , Regulação da Expressão Gênica , Inativação Gênica , Genótipo , Células-Tronco Hematopoéticas/metabolismo , Humanos , Hibridização In Situ , Mutação , Regiões Promotoras Genéticas
10.
Gastroenterol Res Pract ; 2016: 7803262, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26823663

RESUMO

Background and Aims. This study investigated the proportion of CD patients in clinical remission with clinical depression, and coping strategies in those with severe depressive disorders. Materials and Methods. One hundred consecutive CD patients in clinical remission were screened for anxiety and depression by using Hospital Anxiety and Depression Scale and patients with depressive symptoms were further investigated by means of Cognitive Behavioural Assessment 2.0 and Beck Depression Inventory (BDI). Afterwards the coping strategies were assessed through the Brief-COPE questionnaire. Results. Twenty-one patients had anxious symptoms and 16 had depressive symptoms with or without anxiety. Seven of these patients (43.8%) showed significant depressive symptoms. Compared to patients without psychiatric disorders, these patients showed significant lower score in "positive reframing" (p: 0.017) and in "planning" (p: 0.046) and higher score in "use of instrumental social support" (p < 0.001), in "denial" scale (p: 0.001), and in "use of emotional social support" (p: 0.003). Conclusions. Depressed CD patients in clinical remission may have dysfunctional coping strategies, meaning that they may not be able to implement functional strategies to manage at best stress related with their disease.

11.
Blood Cells Mol Dis ; 35(3): 339-44, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16185901

RESUMO

Chromatin insulators are regulatory elements that determine domains of genetic functions. We have previously described the characterization of a 265 bp insulator element, termed sns, localized at the 3' end of the early histone H2A gene of the sea urchin Paracentrotus lividus. This sequence contains three cis-acting elements (Box A, Box B, and Box C + T) all needed for the enhancer-blocking activity in both sea urchin and human cells. The goal of this study was to further characterize the sea urchin sns insulator in the erythroid environment. We employed colony assays in human (K562) and mouse (MEL) erythroid cell lines. We tested the capability of sns to interfere with the communication between the 5'HS2 enhancer of the human beta-globin LCR and the gamma-globin promoter. We found that the sns sequence displays directional enhancer-blocking activity. By the use of antibodies against known DNA binding proteins, in electrophoretic mobility shift assays, we demonstrated the binding of the erythroid-specific GATA-1 and the ubiquitous Oct-1 and Sp1 transcription factors. These factors bind to Box A, Box B, and Box C + T, respectively, in both K562 and MEL nuclear extracts. These results may have significant implications for the conservation of insulator function in evolutionary distant organisms and may prove to be of practical benefit in gene transfer applications for erythroid disorders such as hemoglobinopathies and thalassemias.


Assuntos
Cromatina/fisiologia , Células Eritroides/metabolismo , Elementos Isolantes/fisiologia , Ouriços-do-Mar/genética , Animais , Linhagem Celular , Cromatina/genética , Ensaio de Desvio de Mobilidade Eletroforética , Elementos Facilitadores Genéticos/genética , Fator de Transcrição GATA1/fisiologia , Técnicas de Transferência de Genes , Globinas/genética , Humanos , Elementos Isolantes/genética , Região de Controle de Locus Gênico/fisiologia , Camundongos , Fator 1 de Transcrição de Octâmero/fisiologia , Paracentrotus/genética , Fator de Transcrição Sp1/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA